These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 2143863)
1. Natural killer cell subsets and alloresponsiveness in renal allograft recipients. Shabtai M; Waltzer WC; Pullis CK; Raisbeck AP; Malinowski K; Rapaport FT Transplant Proc; 1990 Aug; 22(4):1846-8. PubMed ID: 2143863 [No Abstract] [Full Text] [Related]
2. T gamma/delta lymphocytes in renal transplant recipients. Raasveld MH; Bloemena E; Surachno S; ten Berge RJ Nephrol Dial Transplant; 1992; 7(6):530-3. PubMed ID: 1377808 [TBL] [Abstract][Full Text] [Related]
3. In situ antigenic modulation of human graft-infiltrating T cells is induced by OKT3 treatment. Caillat-Zucman S; Legendre C; Noel LH; Bach JF; Kreis H; Chatenoud L Transplant Proc; 1990 Aug; 22(4):1782. PubMed ID: 2143860 [No Abstract] [Full Text] [Related]
4. In vivo-in vitro correlates of human rejection using flow cytometry with two-color fluorescence on peripheral blood mononuclear cells. Gross U; Thomas F; Matthews C; Thomas J; Cunningham P; Ritter T Transplant Proc; 1987 Feb; 19(1 Pt 2):1609-10. PubMed ID: 2978885 [No Abstract] [Full Text] [Related]
5. Immunohistological analysis of T lymphocyte subpopulations in needle core biopsies from OKT3-treated renal allograft recipients. Chauhan B; Mohanakumar T; Flye MW Transplantation; 1990 Dec; 50(6):1058-60. PubMed ID: 2147792 [No Abstract] [Full Text] [Related]
6. Phenotypic analysis of CD3 + alpha/beta TCR-cells in allograft recipients and in normal lymphoid tissue. Schwinzer R; Schlitt HJ; Wonigeit K; Pichlmayr R Transplant Proc; 1989 Feb; 21(1 Pt 1):111-2. PubMed ID: 2523117 [No Abstract] [Full Text] [Related]
7. Acute kidney graft rejection. A morphological and immunohistological study on "zero-hour" and follow-up biopsies with special emphasis on cellular infiltrates and adhesion molecules. Andersen CB; Ladefoged SD; Larsen S APMIS; 1994 Jan; 102(1):23-37. PubMed ID: 7513171 [TBL] [Abstract][Full Text] [Related]
8. Prophylactic use of the new monoclonal antibody BMA 031 in clinical kidney transplantation. Smely S; Weschka M; Hillebrand G; Dendorfer U; Krombach F; Kurrle R; Land W; Hammer C Transplant Proc; 1990 Aug; 22(4):1785-6. PubMed ID: 2143862 [No Abstract] [Full Text] [Related]
9. Inverted ratio of CD4/aB heterodimer T cell antigen receptor (TCR aB) to CD8/TCR aB on sorted Leu-7+ (HNK-1) lymphocyte subset in long-term renal allograft recipients. Rodriguez SG; Guttmann RD Transplant Proc; 1989 Feb; 21(1 Pt 1):257-8. PubMed ID: 2495603 [No Abstract] [Full Text] [Related]
10. The Leu-2+7+ cell subset as a marker of immune activation in renal transplant recipients. Brando B; Civati G; Busnach G; Broggi ML; Belli LS; Brunati C; Seveso M; Sommaruga E; Minetti L Transplant Proc; 1987 Feb; 19(1 Pt 2):1611-2. PubMed ID: 2484095 [No Abstract] [Full Text] [Related]
11. Rapid T cell recovery after prophylactic ALG is associated with pancreas allograft rejection. Munn SR; Perkins JD Transplant Proc; 1990 Apr; 22(2):619. PubMed ID: 2139264 [No Abstract] [Full Text] [Related]
12. Cloning of human CD3+ T cells and CD3- natural killer cells and requirements for long-term expansion. van de Griend RJ; Goedegebuure SP; van Krimpen BA; Bolhuis RL Transplant Proc; 1988 Apr; 20(2):149-54. PubMed ID: 2966464 [No Abstract] [Full Text] [Related]
13. CD69 expression on peripheral CD8 T cells correlates with acute rejection in renal transplant recipients. Posselt AM; Vincenti F; Bedolli M; Lantz M; Roberts JP; Hirose R Transplantation; 2003 Jul; 76(1):190-5. PubMed ID: 12865808 [TBL] [Abstract][Full Text] [Related]
14. Lymphocyte subsets and specific T-cell immune response in thalassemia. Pattanapanyasat K; Thepthai C; Lamchiagdhase P; Lerdwana S; Tachavanich K; Thanomsuk P; Wanachiwanawin W; Fucharoen S; Darden JM Cytometry; 2000 Feb; 42(1):11-7. PubMed ID: 10679738 [TBL] [Abstract][Full Text] [Related]
15. Increased frequency of CD8+CD11+ cells expressing the T cell receptor in long-term allograft recipients. Wonigeit K; Schwinzer R; Nashan B; Vogt P; Pichlmayr R Transplant Proc; 1988 Apr; 20(2 Suppl 2):173-8. PubMed ID: 2896404 [No Abstract] [Full Text] [Related]
16. Correlation of pretransplant immune parameters with the rapidity of onset of acute rejection and renal allograft survival time. Shabtai M; Waltzer WC; Pullis CK; Raisbeck A; Shabtai E; Malinowski K; Rapaport FT Transplant Proc; 1990 Aug; 22(4):1917-9. PubMed ID: 2389485 [No Abstract] [Full Text] [Related]
17. The effect of major histocompatibility complex matching on renal pathology and OKT4/OKT8 (CD4/CD8) ratio in renal allograft rejection. Smart YC; Nanra RS; Hibberd AD; Burton RC Transplant Proc; 1987 Feb; 19(1 Pt 2):1627-8. PubMed ID: 3152632 [No Abstract] [Full Text] [Related]
18. Expansion of a CD 3+4-8- TCR alpha/beta- T lymphocyte population in renal allograft recipients. Volk HD; Reinke P; Neuhaus K; Fiebig H; von Baehr R Transplantation; 1989 Mar; 47(3):556-8. PubMed ID: 2646785 [No Abstract] [Full Text] [Related]
19. Expression of the IL-2 receptor (p55 and p75) on peripheral blood lymphocytes in renal transplant recipients. Fujiwara T; Sakagami K; Niguma T; Haisa M; Kawamura T; Kusaka S; Matsuoka J; Shiozaki S; Fujiwara T; Onoda T Transplant Proc; 1991 Feb; 23(1 Pt 1):256-9. PubMed ID: 1824979 [No Abstract] [Full Text] [Related]
20. Cellular immune activation reflects antiviral immunity and is a favorable prognostic marker in patients with cytomegalovirus infection. van den Berg AP; van Son WJ; Tegzess AM; The TH Transplant Proc; 1993 Feb; 25(1 Pt 2):1419-20. PubMed ID: 7680157 [No Abstract] [Full Text] [Related] [Next] [New Search]